Sharon Benzeno sold $312k of ADPT
Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp. 44,665 shares at an average of $6.98, traded Mar 5, 2025, filed Mar 6, 2025.
Score components
- +15RoleOfficer
- +14Trade size$312k at market
- +5Share of holdings soldSold 10% of holdings
- +15Cluster10 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-004815, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 4, 2025 | AGrant or award Common Stock | +109,973 | $0.00 | $0 | 437,388 | Mar 6, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock | -41,600 | $6.98 | $290k | 395,788 | Mar 6, 2025 |
| Mar 5, 2025 | SOpen-market sale Common Stock | -3,065 | $6.99 | $21k | 392,723 | Mar 6, 2025 |
| Mar 4, 2025 | AGrant or award Stock Option (right to buy)derivative | +165,027 | $0.00 | $0 | 165,027 | Mar 6, 2025 |
Related signals
Other insiders at Adaptive Biotechnologies Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $948k 35,643 shares | -9% | |
| 22Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $193k 6,444 shares | -2% | |
| 22Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $758k 26,792 shares | -11% | |
| 25Weak | Adaptive Biotechnologies Corp | Julie Rubinstein President and COO | $1.0M 35,643 shares | -9% | |
| 23Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $3.2M 115,406 shares | -34% | |
| 8Weak | Adaptive Biotechnologies Corp | Susan Bobulsky Chief Commercial Officer, MRD | $32k 1,195 shares | -0% | |
| 0Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $77k 4,394 shares | -1% | |
| 30Weak | Adaptive Biotechnologies Corp | Francis Lo Chief People Officer | $1.8M 113,890 shares | -26% | |
| 55Moderate | Adaptive Biotechnologies Corp | Robert Hershberg director | $367k 22,968 shares | -33% | |
| 7Weak | Adaptive Biotechnologies Corp | Sharon Benzeno Chief Commercial Ofc Imm Med | $212k 12,604 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.